These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18476459)

  • 21. [Atherogenesis as a reflection of immune inflammation in the vascular wall].
    Nagornev VA; Iakovleva OA; Mal'tseva SV
    Vestn Ross Akad Med Nauk; 2000; (10):45-50. PubMed ID: 11247126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production.
    Peng X; Kasran A; Warmerdam PA; de Boer M; Ceuppens JL
    Eur J Immunol; 1996 Jul; 26(7):1621-7. PubMed ID: 8766570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms.
    Varadhachary AS; Monestier M; Salgame P
    Cell Immunol; 2001 Oct; 213(1):45-51. PubMed ID: 11747355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice.
    Tang J; Kozaki K; Farr AG; Martin PJ; Lindahl P; Betsholtz C; Raines EW
    Am J Pathol; 2005 Sep; 167(3):901-12. PubMed ID: 16127167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice.
    Buono C; Pang H; Uchida Y; Libby P; Sharpe AH; Lichtman AH
    Circulation; 2004 Apr; 109(16):2009-15. PubMed ID: 15096453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesis.
    Jawien J
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2435-9. PubMed ID: 22280417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerosis is an inflammatory disease.
    Ross R
    Am Heart J; 1999 Nov; 138(5 Pt 2):S419-20. PubMed ID: 10539839
    [No Abstract]   [Full Text] [Related]  

  • 28. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
    Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
    J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines, immuno-inflammatory response and atherosclerosis.
    Tedgui A; Bernard C
    Eur Cytokine Netw; 1994; 5(3):263-70. PubMed ID: 7948763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation.
    DeGraba TJ
    Stroke; 2004 Nov; 35(11 Suppl 1):2712-9. PubMed ID: 15472106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse.
    Sugimoto T; Ishikawa Y; Yoshimoto T; Hayashi N; Fujimoto J; Nakanishi K
    J Exp Med; 2004 Feb; 199(4):535-45. PubMed ID: 14970180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
    Sebbag M; Parry SL; Brennan FM; Feldmann M
    Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atherosclerosis: a classic inflammatory disease.
    Anogeianaki A; Angelucci D; Cianchetti E; D'Alessandro M; Maccauro G; Saggini A; Salini V; Caraffa A; Tete S; Conti F; Tripodi D; Shaik-Dasthagirisaheb YB
    Int J Immunopathol Pharmacol; 2011; 24(4):817-25. PubMed ID: 22230389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation to combat atherosclerosis: the potential role of immune regulatory cells.
    Mallat Z; Tedgui A
    Expert Opin Biol Ther; 2004 Sep; 4(9):1387-93. PubMed ID: 15335306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kinetics of vascular wall cells and atherogenesis].
    Nagornev VA
    Arkh Patol; 1998; 60(1):39-43. PubMed ID: 9582988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice.
    Brånén L; Hovgaard L; Nitulescu M; Bengtsson E; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2137-42. PubMed ID: 15345516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice.
    Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1474-8. PubMed ID: 15178562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunity, inflammation and atherosclerosis].
    Capron L
    Rev Neurol (Paris); 1993; 149(12):751-4. PubMed ID: 7997733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis.
    Mangge H; Hubmann H; Pilz S; Schauenstein K; Renner W; März W
    Clin Chem Lab Med; 2004 May; 42(5):467-74. PubMed ID: 15202781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
    Zirlik A; Bavendiek U; Libby P; MacFarlane L; Gerdes N; Jagielska J; Ernst S; Aikawa M; Nakano H; Tsitsikov E; Schönbeck U
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1101-7. PubMed ID: 17332487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.